BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23528732)

  • 21. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.
    Patterson LJ; Malkevitch N; Venzon D; Pinczewski J; Gómez-Román VR; Wang L; Kalyanaraman VS; Markham PD; Robey FA; Robert-Guroff M
    J Virol; 2004 Mar; 78(5):2212-21. PubMed ID: 14963117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
    Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.
    Doria-Rose NA; Ohlen C; Polacino P; Pierce CC; Hensel MT; Kuller L; Mulvania T; Anderson D; Greenberg PD; Hu SL; Haigwood NL
    J Virol; 2003 Nov; 77(21):11563-77. PubMed ID: 14557642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.
    Demberg T; Ettinger AC; Aladi S; McKinnon K; Kuddo T; Venzon D; Patterson LJ; Phillips TM; Robert-Guroff M
    Vaccine; 2011 Aug; 29(35):6017-28. PubMed ID: 21708207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
    Schell JB; Rose NF; Bahl K; Diller K; Buonocore L; Hunter M; Marx PA; Gambhira R; Tang H; Montefiori DC; Johnson WE; Rose JK
    J Virol; 2011 Jun; 85(12):5764-72. PubMed ID: 21490100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.
    Kaur A; Sanford HB; Garry D; Lang S; Klumpp SA; Watanabe D; Bronson RT; Lifson JD; Rosati M; Pavlakis GN; Felber BK; Knipe DM; Desrosiers RC
    Virology; 2007 Jan; 357(2):199-214. PubMed ID: 16962628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.
    Sundling C; O'Dell S; Douagi I; Forsell MN; Mörner A; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
    J Virol; 2010 Sep; 84(18):9086-95. PubMed ID: 20610729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge.
    Rosati M; Bergamaschi C; Valentin A; Kulkarni V; Jalah R; Alicea C; Patel V; von Gegerfelt AS; Montefiori DC; Venzon DJ; Khan AS; Draghia-Akli R; Van Rompay KK; Felber BK; Pavlakis GN
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15831-6. PubMed ID: 19717425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
    McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
    J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.
    Bachler BC; Humbert M; Lakhashe SK; Rasmussen RA; Ruprecht RM
    Retrovirology; 2013 Jun; 10():63. PubMed ID: 23800339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
    Demberg T; Boyer JD; Malkevich N; Patterson LJ; Venzon D; Summers EL; Kalisz I; Kalyanaraman VS; Lee EM; Weiner DB; Robert-Guroff M
    J Virol; 2008 Nov; 82(21):10911-21. PubMed ID: 18753198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
    Buge SL; Richardson E; Alipanah S; Markham P; Cheng S; Kalyan N; Miller CJ; Lubeck M; Udem S; Eldridge J; Robert-Guroff M
    J Virol; 1997 Nov; 71(11):8531-41. PubMed ID: 9343211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
    Xiao P; Patterson LJ; Kuate S; Brocca-Cofano E; Thomas MA; Venzon D; Zhao J; DiPasquale J; Fenizia C; Lee EM; Kalisz I; Kalyanaraman VS; Pal R; Montefiori D; Keele BF; Robert-Guroff M
    J Virol; 2012 Apr; 86(8):4644-57. PubMed ID: 22345466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.
    Hidajat R; Xiao P; Zhou Q; Venzon D; Summers LE; Kalyanaraman VS; Montefiori DC; Robert-Guroff M
    J Virol; 2009 Jan; 83(2):791-801. PubMed ID: 18971271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
    Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
    J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge.
    Tuero I; Mohanram V; Musich T; Miller L; Vargas-Inchaustegui DA; Demberg T; Venzon D; Kalisz I; Kalyanaraman VS; Pal R; Ferrari MG; LaBranche C; Montefiori DC; Rao M; Vaccari M; Franchini G; Barnett SW; Robert-Guroff M
    PLoS Pathog; 2015 Aug; 11(8):e1005101. PubMed ID: 26267144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques.
    Jaworski JP; Bryk P; Brower Z; Zheng B; Hessell AJ; Rosenberg AF; Wu TT; Sanz I; Keefer MC; Haigwood NL; Kobie JJ
    PLoS One; 2017; 12(2):e0172524. PubMed ID: 28222180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.